2 employees
NeOnc Technologies develops intranasal inhalation dosing therapies for the treatment of brain and lung cancers.
2008
$10M
from 3 investors over 3 rounds
NEONC Technologies raised $10M on February 8, 2023
Investors: Handshake Ventures, Orion BioScience and Li Family Office